The optimal management of cardioversion of atrial fibrillation or flutter: still a 'stunning' problem.
Stellbrink
C
C
Hanrath
P
P
D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000628:therapy*; D001282:Atrial Flutter / Q000150:complications / Q000628:therapy*; D003328:Coronary Thrombosis / Q000209:etiology; D017548:Echocardiography, Transesophageal; D004554:Electric Countershock; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D018570:Risk Assessment
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight